Johnson & Johnson vs Invesco Solar ETF — how do they compare? Johnson & Johnson trades at $259.89 (market cap $626.09B), while Invesco Solar ETF trades at $52.39. The key difference: Johnson & Johnson pays a 2.06% dividend while Invesco Solar ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | TAN | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Sector/Thematic |
52-Week High | $267.24 | $73.95 |
52-Week Low | $172.78 | $36.62 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
TAN trades at $52.41, up 1.06% in the last session, amid a bearish technical signal with selling pressure outweighing buys 11 to 4. Recent news highlights solar sector volatility and policy impacts, including new polysilicon tariffs under the Trump administration that may reshape U.S. solar manufacturing dynamics. The ETF's high beta of 1.41 indicates elevated sensitivity to market swings compared to broader energy funds.
Outlook is mixed: tariffs could boost U.S.-focused solar stocks but face headwinds from permit delays and weak residential demand. Risks include regulatory uncertainty and competition from nuclear energy. Analyst sentiment is cautious, with downgrades citing valuation and technical deterioration, though long-term growth drivers like AI energy demand persist.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →